Deciphera Pharmaceuticals, Inc. (DCPH) News
Filter DCPH News Items
DCPH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DCPH News Highlights
- For DCPH, its 30 day story count is now at 3.
- Over the past 8 days, the trend for DCPH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest DCPH News From Around the Web
Below are the latest news stories about DECIPHERA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate DCPH as an investment opportunity.
Deciphera Pharmaceuticals CEO Steven Hoerter Sells Over 30,000 SharesSteven Hoerter, the President and CEO of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH), has recently sold a significant number of shares in the company. |
Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Intrinsic Value Is Potentially 97% Above Its Share PriceKey Insights The projected fair value for Deciphera Pharmaceuticals is US$29.64 based on 2 Stage Free Cash Flow to... |
Bluebird (BLUE) Up 48.2% Since Last Earnings Report: Can It Continue?Bluebird (BLUE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Insider Sell Alert: Daniel Martin of Deciphera Pharmaceuticals Inc Cashes Out SharesIn the realm of biopharmaceuticals, insider trading activity often garners significant attention from investors seeking to understand the internal perspectives of a company's executives. |
Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue?Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 1.7% Since Last Earnings Report?Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitWALTHAM, Mass., November 29, 2023--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit on Wednesday, December 6, 2023 at 1:30 PM ET. |
Deciphera Pharmaceuticals to Participate in Upcoming Investor ConferencesWALTHAM, Mass., November 07, 2023--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences: |
Deciphera Pharmaceuticals Inc CEO Steven Hoerter Sells 21,573 SharesOn October 30, 2023, President and CEO Steven Hoerter sold 21,573 shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH). |